Navigation Links
Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
Date:7/12/2013

WORCESTER, Mass. and TORONTO, July 12, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced particulars of the conference call it will be hosting featuring members of the Antigen Express, Inc. (www.antigenexpress.com) Scientific Advisory Board.

The conference call will take place on Wednesday, August 14, 2013 at 10 a.m. EDT.  Call-in particulars will be announced prior to the call.

The following members of the Antigen Express Scientific Advisory Board will be the panelists on the call:

  • Dr. Gary H. Lyman, MD, MPH, FACP, FRCP (Edin), FASCO is a Professor of Medicine at Duke University School of Medicine, Director of the Comparative Effectiveness and Outcomes Research Program, a Senior Fellow at the Duke Center for Clinical Health Policy Research, and a member of the Duke Cancer Institute and Duke Center for Personalized Medicine.  An ASCO member since 1977, Dr. Lyman is a member of the ASCO Board of Directors and Chair-Elect of the Clinical Practice Guidelines Committee and serves on the Editorial Board of the Journal of Clinical Oncology.
  • Dr. Gabriel N. Hortobagyi, MD, FACP chairs the department of Breast Medical Oncology and directs the Breast Cancer Research Program at the University of Texas M.D. Anderson Cancer Center, where he also serves as Professor of Medicine and holds the Nellie B. Connally Chair in Breast Cancer.
  • Dr. Ian Krop, MD, PhD is an Assistant Professor of Medicine and Director of Clinical Research for the Breast Oncology Center at the Dana-Farber Cancer Institute, Harvard Medical School.
  • Dr. Keith L. Knutson, PhD is Oncology Program
    '/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
2. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
3. Generex Announces Date of Annual Stockholders Meeting
4. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
5. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
6. Generex Secures Commitments for $3.6M Capital Raise
7. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
8. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
9. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
10. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
11. Averica Discovery Announces Winner of First Averica Award for Supercritical Fluid Chromatography (SFC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... Executive Officer of Regulus, will present a company overview ... Healthcare Conference on Wednesday, March 4, 2015 at 9:20 ... Boston Marriott Copley Place.  The presentation ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... 2015 The Pittcon 2015 Exposition, ... Ernest N. Morial Convention Center in New Orleans, ... February 19, 2015) displaying products and services used ... government labs. The Exposition will offer the latest ... to, analytical chemistry; drug discovery; nanotechnology; life sciences ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
Breaking Biology Technology:Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3
... Favrille, Inc. (Nasdaq:,FVRL) today announced that it ... 2008 indicating that, for the last 30 consecutive ... common stock has been below,the minimum $1.00 per ... $5,000,000 minimum market value of publicly held shares ...
... the ... Treatment of Stuttering, ROANOKE, Va., ... non-profit research and,clinical center ( http://www.stuttering.org ) specializing ... stuttering,therapy with advanced behavioral, electronic and computer technologies that,significantly improve ...
... for Aging Services Technologies, (CAST) to Expedite Emerging ... 15 Samarion CEO Mark Rodgers was,recently named ... to help lead the charge to expedite emerging ... an international coalition ensuring that technology solutions,attain their ...
Cached Biology Technology:Favrille Announces Receipt of Nasdaq Letters 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 3Samarion CEO Mark Rodgers Named CAST Commissioner 2
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/11/2015)... , February 11, 2015 ... report "Access Control Market by Product (Cards and Readers, ... Military and Defense, Government, Industrial, Healthcare, Education) and By ... by MarketsandMarkets, the Access Control Market is ... growing at a CAGR of 10.6% between ...
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... HAIFA, Israel , April 27, 2010 Oil Refineries,Ltd. (TASE: ... its Annual & Special General,Meeting scheduled for Monday, April 26, 2010 to Monday, ... remains the same. , , , ... , , ...
... , April 27, 2010 Cellcom Israel,Ltd. (NYSE: ... of a purported,class action lawsuit filed in March 2009 ... by a plaintiff alleging to be the Company,s,subscriber, in connection ... The purported class action was dismissed,without prejudice, following the request ...
... Tuesday morning between Temple University Hospital (TUH) and the Pennsylvania Association of ... resume later today at 1:00 p.m. , ... Continued progress was reported, but the parties remain apart on economics. , ... Temple University Hospital is committed to meet with the ...
Cached Biology News:Oil Refineries Announces Delay to Annual & Special General Meeting 2Cellcom Israel Ltd. Announces Dismissal of a Purported Class Action 2
... 2-3x faster than western blotting. Get results ... Direct on gel detection. Eliminates the need ... detection methods. All reagents are ready-to-use. No ... to use. Only 2 reagents required. Guarantees a ...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is ... vitro transposition system developed by Goryshin and ... generation of nested families of deletions and ... cloned in a transposon-containing plasmid vector. Although ...
... This kit is designed to knockout or alter ... less than one week. Red/ET recombination allows the ... precise, specific, and faithful manner. An FRT-flanked kanamycin ... which can be used to replace a gene ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: